Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation in Severe Multiple Sclerosis. The Brazilian Experience with Two Conditioning Regimes: BEAM and High-Dose Cyclophosphamide.

Julio C Voltarelli, Md, PhD, Marina A. Coutinho, MD, MSc, Ana Beatriz P.L. Stracieri, MD, PhD, Maria Carolina B. Oliveira, MD, MSc, Daniela A. Moraes, MD, MSc, Fabiano Pieroni, MD, PhD, Belinda P. Simoes, MD, PhD, George M.N. Barros, MD, Amilton F. Ribeiro, MD, PhD, Nelson Hamerschlak, MD, Cesar Leite, MD, Jose Zanis, MD

Blood (2007) 110 (11): 2881.

https://doi.org/10.1182/blood.V110.11.2881.2881

Published: 2007

Journal Articles

Haploidentical Stem Cell Transplantation without T Cell Depletion: A Brazilian Protocol.

Belinda P. Simoes, MD, PhD, George Navarro, MD, Maria C. Favarin, MD, Leonardo C. Palma, MD, Maria I. Ayrosa, MD, Carlos E. Velano, MD, Fabiano Pieroni, MD, PhD, Ana Beatriz P.L. Stracieri, MD, PhD, Daniela Moraes, MD, Maria C. Oliveira, MD, Julio C. Voltarelli, MD, PhD

Blood (2006) 108 (11): 5413.

https://doi.org/10.1182/blood.V108.11.5413.5413

Published: 2006

Journal Articles

Acute Myeloid Leukemia (AML-M2) with a Novel Translocation t(5;11)(q35;q13) and Normal Expression of Cyclin D1.

Fabio M. de Oliveira, MS, Guilherme A.S. dos Santos, MD, Andre F. Marinato, MD, Amelia G. Araujo, Ana S.G. Lima, PhD, Rafael H. Jacomo, MD, Roberto P. Falcao, MD, PhD, Luis G. Tone, MD, PhD, Belinda P. Simoes, MD, PhD, Eduardo M. Rego, MD, PhD

Blood (2005) 106 (11): 4538.

https://doi.org/10.1182/blood.V106.11.4538.4538

Published: 2005

Journal Articles

Fludarabine and Oral Busulfan: A Low Toxicity Conditioning Regimen When Plasma Level Targeting and Intravenous Busulfan Is Not Available. A Brazilian Experience.

Belinda P. Simoes, MD, PhD, M. Souza, MD, Marcos Mauad, MD, Eduardo J.A. Paton, MD, Fabiano Pieroni, MD, PhD, Ana B.P.L. Stracieri, MD, PhD, Maria C. Oliveira, MD, Daniela Moraes, MD, Marina Coutinho, MD, Julio C. Voltarelli, MD, PhD, Vergilio R. Colturato, MD

Blood (2005) 106 (11): 5302.

https://doi.org/10.1182/blood.V106.11.5302.5302

Published: 2005

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation for Type I Diabetes Mellitus.

Julio C. Voltarelli, MD PhD, Carlos E.B. Couri, MD, Maria-Carolina B. Oliveira, MD, Ana-Beatriz P.L. Stracieri, MD PhD, Daniela A. Moraes, MD, Dannielle F. Godoi, MD, Marina A. Coutinho, MD MsC, Kelen C.R. Malmegrim, BsC, Maria-Cristina Foss-Freitas, MD, Milton C. Foss, MD PhD, Belinda P. Simoes, MD PhD, Elizabeth C. Squiers, MD, Richard K. Burt, MD

Blood (2004) 104 (11): 5224.

https://doi.org/10.1182/blood.V104.11.5224.5224

Published: 2004

NARROW

Autologous Hematopoietic Stem Cell Transplantation in Severe Multiple Sclerosis. The Brazilian Experience with Two Conditioning Regimes: BEAM and High-Dose Cyclophosphamide.

Haploidentical Stem Cell Transplantation without T Cell Depletion: A Brazilian Protocol.

Acute Myeloid Leukemia (AML-M2) with a Novel Translocation t(5;11)(q35;q13) and Normal Expression of Cyclin D1.

Fludarabine and Oral Busulfan: A Low Toxicity Conditioning Regimen When Plasma Level Targeting and Intravenous Busulfan Is Not Available. A Brazilian Experience.

Autologous Hematopoietic Stem Cell Transplantation for Type I Diabetes Mellitus.

Email alerts

ASH Publications

American Society of Hematology

Autologous Hematopoietic Stem Cell Transplantation in Severe Multiple Sclerosis. The Brazilian Experience with Two Conditioning Regimes: BEAM and High-Dose Cyclophosphamide.

Haploidentical Stem Cell Transplantation without T Cell Depletion: A Brazilian Protocol.

Acute Myeloid Leukemia (AML-M2) with a Novel Translocation t(5;11)(q35;q13) and Normal Expression of Cyclin D1.

Fludarabine and Oral Busulfan: A Low Toxicity Conditioning Regimen When Plasma Level Targeting and Intravenous Busulfan Is Not Available. A Brazilian Experience.

Autologous Hematopoietic Stem Cell Transplantation for Type I Diabetes Mellitus.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only